Nonsulfated, cinnamic acid-based lignins are potent antagonists of HSV-1 entry into cells.
In an effort to discover macromolecular mimetics of heparan sulfate (HS), we previously designed sulfated lignins (Raghuraman et al. Biomacromolecules 2007, 8, 1759-1763). To probe the relevance of sulfate groups of HS in viral entry, lignins completely devoid of sulfate moieties, and yet possessing an electrostatic surface equivalent to that of HS, were designed. Two carboxylated lignins based on a 4-hydroxy cinnamic acid scaffold were synthesized using enzymatic oxidative coupling in high yields, fractionated according to their sizes, and tested in cellular assays of herpes simplex virus-1 (HSV-1) infection. The two carboxylated lignins were found to not only inhibit HSV-1 entry into mammalian cells (IC(50) = 8-56 nM), but were more potent than sulfated lignins. In addition, shorter carboxylated lignins were found to be as active as the longer chains, suggesting that structural features, in addition to carboxylate groups, may be important. It can be expected that carboxylated lignins also antagonize the entry of other enveloped viruses, for example, HIV-1, Kaposi's sarcoma-associated herpes virus, and hepatitis C virus, that utilize HS to gain entry into cells. The results present major opportunities for developing lignin-based antiviral formulations for topical use.
Thakkar
Jay N
JN
Department of Medicinal Chemistry and Institute for Structural Biology and Drug Discovery, Virginia Commonwealth University, 800 East Leigh Street, Suite 212, Richmond, Virginia 23219, USA.
Tiwari
Vaibhav
V
Desai
Umesh R
UR
D000998:Antiviral Agents / Q000494:pharmacology*; D002459:Cell Fusion; D002934:Cinnamates / Q000737:chemistry*; D018259:Herpesvirus 1, Human / Q000502:physiology*; D006801:Humans; D008031:Lignin / Q000737:chemistry / Q000494:pharmacology*; D008970:Molecular Weight
D000998:Antiviral Agents; D002934:Cinnamates; C029010:cinnamic acid; D008031:Lignin
Annu Rev Plant Biol. 2003;54:519-46
14503002
Comp Biochem Physiol B Biochem Mol Biol. 2006 Jan;143(1):37-43
16298150
Chem Pharm Bull (Tokyo). 1992 Aug;40(8):2102-5
1423763
Biomacromolecules. 2008 Dec;9(12):3378-82
18991457
J Biol Chem. 2007 Nov 2;282(44):31891-9
17804413
Biol Pharm Bull. 1993 Apr;16(4):434-6
8358397
Mass Spectrom Rev. 2004 Mar-Apr;23(2):87-126
14732934
Curr Med Chem. 2004 Sep;11(18):2399-419
15379705
Phytochemistry. 2009 Jan;70(1):147-55
19056096
Cell. 1996 Nov 1;87(3):427-36
8898196
J Agric Food Chem. 2003 Feb 12;51(4):981-6
12568559
Biomacromolecules. 2007 May;8(5):1759-63
17439173
J Agric Food Chem. 1999 Aug;47(8):3325-31
10552653
J Agric Food Chem. 2008 Nov 12;56(21):10368-75
18841901
Biomacromolecules. 2005 Sep-Oct;6(5):2822-32
16153124
J Biol Chem. 2001 Jun 1;276(22):18734-41
11278569
Curr Pharm Des. 2009;15(25):2946-57
19754371
Virology. 2010 Feb 20;397(2):389-98
20004926
Biosci Biotechnol Biochem. 1999 Dec;63(12):2202-4
10664853
Cell. 1999 Oct 1;99(1):13-22
10520990
Comp Biochem Physiol C Toxicol Pharmacol. 2003 Dec;136(4):357-65
15012907
Tetrahedron. 2010 Apr 17;66(16):2907-2918
20689724
Virology. 1998 Jun 20;246(1):179-89
9657005
Virol Sin. 2008 Dec 1;23(6):383-393
19956628
Bioorg Med Chem. 2006 Dec 1;14(23):7988-98
16914317
J Gen Virol. 2004 Apr;85(Pt 4):805-809
15039523
Tetrahedron Lett. 2007 Sep 17;48(38):6754-6758
18797498
Org Biomol Chem. 2003 Jan 21;1(2):268-81
12929422